Trostberg, June 3, 2019 – The Supervisory Board of AlzChem Group AG has decided to appoint Mr. Andreas Niedermaier (CFO) as the new CEO with effect from July 1, 2019, in view of the resignation of... read more
News
| 2019-06-03
| 2019-01-23
The AlzChem image film presents the company as a group that focuses on know-how, research and technology – but that is also shaped by the people who work here. The four-minute video gives an insight... read more
| 2018-09-13
At the first creatine deficiency syndrome (CCDS) symposium in Austin, Texas, which AlzChem sponsored, several patients reported positive treatment outcomes with creatine. Creatine is an endogenous... read more
| 2018-05-09
Trostberg. Amidines are organic chemical compounds with an NCN structure, meaning a typical nitrogen-carbon-nitrogen sequence. These types of chemicals are one of AlzChem’s core competencies. NCN... read more
| 2018-04-18
AlzChem released 39 trainees into professional life – well equipped and with excellent grades.
At a traditional ceremony on April 12, 2018, the management of AlzChem and BASF discharged 39... read more
| 2018-03-16
A traditional groundbreaking ceremony on March 16 officially opened construction on AlzChem Group AG’s new production plant in Trostberg for the feed additive CreAMINO®1. Dr. Peter Ramsauer (MdB),... read more
| 2018-02-28
Thiourea is a key raw material for a wide variety of applications and industries. As an established global partner of the chemical industry, AlzChem is the only supplier of thiourea outside of Asia... read more
| 2017-12-08
Today, our majority shareholders LIVIA Corporate Development SE, HDI Vier CE GmbH and Edelweiß Holding GmbH notified us that the intended placement of up to 18,000,000 shares was canceled.
About... read more
| 2017-12-07
Today, our majority shareholders LIVIA Corporate Development SE, HDI Vier CE GmbH and Edelweiß Holding GmbH notified us of their intention to place up to 18,000,000 shares, corresponding to... read more
| 2017-02-07
Specialty chemical supplier AlzChem AG postpones planned IPO
Trostberg, February 7, 2017 – AlzChem AG (together with its subsidiaries hereinafter “AlzChem”), a vertically integrated specialty... read more